News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
152,230 Results
Type
Article (6812)
Company Profile (52)
Press Release (145360)
Multimedia
Podcasts (9)
Webinars (1)
Section
Business (37952)
Career Advice (164)
Deals (9083)
Drug Delivery (13)
Drug Development (21847)
Employer Resources (17)
FDA (3691)
Job Trends (3258)
News (72485)
Policy (6417)
Tag
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (504)
Accelerated approval (10)
Adcomms (5)
Allergies (32)
Alliances (9268)
ALS (39)
Alzheimer's disease (358)
Antibody-drug conjugate (ADC) (72)
Approvals (3909)
Artificial intelligence (62)
Autoimmune disease (35)
Automation (5)
Bankruptcy (59)
Best Places to Work (2897)
BIOSECURE Act (1)
Biosimilars (48)
Biotechnology (32)
Bladder cancer (61)
Brain cancer (11)
Breast cancer (203)
Cancer (1438)
Cardiovascular disease (166)
Career advice (150)
Career pathing (6)
CAR-T (46)
Cell therapy (150)
Cervical cancer (11)
Clinical research (19439)
Collaboration (358)
Compensation (1097)
Complete response letters (5)
COVID-19 (565)
CRISPR (21)
C-suite (210)
Cystic fibrosis (44)
Data (2089)
Denatured (4)
Depression (25)
Diabetes (198)
Diagnostics (1391)
Digital health (9)
Diversity, equity & inclusion (7)
Drug discovery (42)
Drug pricing (13)
Drug shortages (2)
Duchenne muscular dystrophy (47)
Earnings (16521)
Editorial (7)
Employer branding (3)
Employer resources (18)
Events (25206)
Executive appointments (215)
FDA (4700)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (369)
Gene editing (54)
Generative AI (2)
Gene therapy (143)
GLP-1 (259)
Government (818)
Grass and pollen (1)
Guidances (133)
Healthcare (4396)
HIV (22)
Huntington's disease (14)
IgA nephropathy (17)
Immunology and inflammation (44)
Immuno-oncology (13)
Indications (39)
Infectious disease (637)
Inflammatory bowel disease (47)
Influenza (35)
Intellectual property (48)
Interviews (19)
IPO (5797)
IRA (6)
Job creations (553)
Job search strategy (120)
JPM (12)
Kidney cancer (6)
Labor market (3)
Layoffs (93)
Leadership (13)
Legal (1167)
Liver cancer (30)
Longevity (4)
Lung cancer (262)
Lymphoma (129)
Machine learning (7)
Management (6)
Manufacturing (212)
MASH (51)
Medical device (2591)
Medtech (2599)
Mergers & acquisitions (3645)
Metabolic disorders (342)
Multiple sclerosis (31)
NASH (3)
Neurodegenerative disease (68)
Neuropsychiatric disorders (17)
Neuroscience (636)
NextGen: Class of 2026 (1352)
Non-profit (1486)
Now hiring (9)
Obesity (92)
Opinion (40)
Ovarian cancer (45)
Pain (35)
Pancreatic cancer (64)
Parkinson's disease (68)
Partnered (3)
Patents (88)
Patient recruitment (100)
Peanut (8)
People (11537)
Pharmaceutical (10)
Pharmacy benefit managers (4)
Phase 1 (5307)
Phase 2 (8578)
Phase 3 (7185)
Pipeline (1585)
Policy (19)
Postmarket research (755)
Preclinical (2285)
Press Release (14)
Prostate cancer (59)
Psychedelics (9)
Radiopharmaceuticals (64)
Rare diseases (225)
Real estate (1172)
Recruiting (4)
Regulatory (5685)
Reports (7)
Research institute (493)
Resumes & cover letters (23)
Rett syndrome (5)
RNA editing (4)
RSV (21)
Schizophrenia (43)
Series A (39)
Series B (32)
Service/supplier (4)
Sickle cell disease (26)
Special edition (1)
Spinal muscular atrophy (32)
Sponsored (10)
Startups (723)
State (1)
Stomach cancer (1)
Supply chain (17)
Tariffs (4)
The Weekly (5)
Vaccines (174)
Venture capital (26)
Weight loss (51)
Women's health (21)
Worklife (2)
Date
Today (2)
Last 7 days (176)
Last 30 days (627)
Last 365 days (8801)
2026 (802)
2025 (8813)
2024 (9385)
2023 (10237)
2022 (12609)
2021 (14013)
2020 (12610)
2019 (10645)
2018 (7897)
2017 (7224)
2016 (6293)
2015 (7475)
2014 (5408)
2013 (4345)
2012 (4661)
2011 (5063)
2010 (4584)
Location
Africa (108)
Alabama (6)
Arizona (51)
Arkansas (1)
Asia (7484)
Australia (1289)
California (3104)
Canada (823)
China (245)
Colorado (113)
Connecticut (176)
Delaware (145)
Europe (21372)
Florida (505)
Georgia (91)
Hawaii (1)
Idaho (10)
Illinois (219)
India (13)
Indiana (209)
Iowa (4)
Japan (143)
Kansas (37)
Kentucky (18)
Louisiana (9)
Maine (16)
Maryland (384)
Massachusetts (2241)
Michigan (55)
Minnesota (120)
Missouri (45)
Montana (2)
Nebraska (6)
Nevada (25)
New Hampshire (5)
New Jersey (935)
New Mexico (3)
New York (775)
North Carolina (1421)
North Dakota (5)
Northern California (1609)
Ohio (132)
Oklahoma (5)
Oregon (8)
Pennsylvania (585)
Puerto Rico (5)
Rhode Island (10)
South America (229)
South Carolina (55)
Southern California (1174)
Tennessee (14)
Texas (446)
United States (11996)
Utah (75)
Virginia (57)
Washington D.C. (43)
Washington State (275)
West Virginia (1)
Wisconsin (34)
152,230 Results for "c lecta".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
c-LEcta Reports Record Year With Significant Growth - Aug 23, 2022
c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, successfully continued its dynamic business development in fiscal year 2021.
August 23, 2022
·
6 min read
Drug pricing
Before GLP-1s, a Great Pricing Battle Played Out in Hep C Market
The introduction of AbbVie’s hepatitis C drugs in 2014 forced Gilead’s hand in the fight for market dominance in hepatitis C. A similar dynamic is now playing out between Eli Lilly and Novo Nordisk in the obesity space, with some key differences.
November 18, 2025
·
7 min read
·
Annalee Armstrong
Press Releases
/C O R R E C T I O N -- Chamber Cardio/
February 5, 2026
·
3 min read
Deals
c-LEcta Announces That It Has Reached Agreement to Be Acquired by Kerry Group
c-LEcta has announced that it has reached an agreement with Kerry Group for it to acquire a majority shareholding of the company.
February 15, 2022
·
3 min read
Press Releases
/C O R R E C T I O N -- Privo Technologies/
January 26, 2026
·
2 min read
Press Releases
/C O R R E C T I O N -- Orasis Pharmaceuticals/
January 28, 2026
·
8 min read
Press Releases
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - January 26, 2026
January 27, 2026
·
1 min read
c-LEcta Expands Product Range to Include Additional Enzyme NuCLEANase®
c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, is launching a newly developed enzyme product.
November 11, 2021
·
3 min read
c-LEcta Continues Its Growth in 2021 and Sees Itself Excellently Positioned for the Future With the ENESYZ Technology Platform
c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, continued its growth in 2021.
December 16, 2021
·
4 min read
Press Releases
OKYO Pharma Announces Successful Type C Meeting with the FDA
January 29, 2026
·
5 min read
1 of 15,223
Next
